Dr. Mendez Fernandez - ND.

Dr. Mendez Fernandez - ND. I am a certified Naturopathic Medical Doctor, Researcher, & Nutraceutical Scientist based in Lusaka, Zambia.

I am a certified Naturopath Medical Doctor, Researcher, & Nutraceutical Scientist.

TOPVEIN-B6 & CONSTIPATION ----------------------------------------------------------------------------Soon after taking ...
14/04/2026

TOPVEIN-B6 & CONSTIPATION
----------------------------------------------------------------------------

Soon after taking the first cup of TOPVEIN-B6, your stool, suddenly becomes softer or in some cases, you may experience loose stool like diarrhea.

Do not panic.

That is a very good sign.

And do not take any other medications to stop the loose stool.

This is the beginning of your journey to great health and healing.

Stools are not supposed to be hard or like rockstone.

How would the bowels release hard stool?

To enjoy your toilet time and ensure complete release of the waste from the drainage pipe, stool ought to be soft.

HIV & CONSTIPATION:
----------------------------------------------------------------------------
Having been dealing with HIV positive people globally for about 16 years today, one of the common threads in these individuals, is the experience of constipation.

Most do not experience a once off form of constipation but are chronically constipated.

In other words, their bowels do not completely release the dirt out. They may attend the toilets but do not release what needs to be released completely.

A small portion of the dirt is released while a large portion remains in the bowels.

Overtime, the unreleased dirt clogs in the bowels.

This is similar to a drainage being blocked or a sink drainage pipe being clogged up with stuff which collects overtime.

If your intestinal drainage is clogged up overtime, what happens is that, the body begins to re-digest the same waste it prepared for discarding.

This re-digested waste in the bowels causes toxicity of the blood stream as the toxins which were once considered as waste and needed discarding off the drainage, ended up clogging up the drainage system overtime and sip into the blood stream due to a leaking gut.

These are the toxins which end up causing chronic immune system activation and gastrointestinal tract health problems associated with HIV as opportunistic infections and diseases.

GASTROINTESTINAL TRACK INFECTIONS

I will discuss these opportunistic infections and diseases of the gastrointestinal tract due to constipation in my next article.

WHY TOPVEIN-B6 IS THE BEST MEDICINE FOR HIV/AIDS?  TOPVEIN-B6 is not only effective in preventing HIV from entering cell...
08/04/2026

WHY TOPVEIN-B6 IS THE BEST MEDICINE FOR HIV/AIDS?

TOPVEIN-B6 is not only effective in preventing HIV from entering cells; it also protects all newly produced cells from HIV infection.

Beyond its antiviral properties, TOPVEIN-B6 treats, prevents, and safeguards cells against opportunistic infections and diseases commonly associated with HIV.

Understanding the Context:

When someone tests positive for HIV, commonly understood as infection with the virus that causes AIDS, one important question is rarely addressed:

How many cells in the body are actually infected or affected by the virus?

Research shows that only about 0.01% to 0.10% of the body's cells are infected with HIV at any given time, with some estimates rising to 0.25% to 0.5%. In other words, just 1 in 400 to 1 in 200 cells is affected. The percentage of CD4+ T cells infected is also typically very low.

This explains why HIV alone does not directly cause death or significant disease, nor is it solely responsible for the overall loss of immune cells.

The real danger lies in the conditions HIV creates, which prevent the immune system from repairing itself, leading to a gradual decline in immune function.

Key Factors Leading to Immune System Decline:

1. Chronic Immune Activation:

HIV causes ongoing stimulation of the immune system, largely due to microbial translocation, leakage of toxins or bacteria from a damaged gut into the bloodstream.

Early in HIV infection, CD4+ T cells in the gut are preferentially depleted, undermining the body's first line of defense against intestinal pathogens and damaging the immune system's ability to regenerate. Over time, this relentless immune assault exhausts T cells, leading to premature cell aging and death.

2. Chronic Inflammation:

Constant immune activation results in persistent inflammation, which damages tissues and further impairs immune function.

Simply put, the amount of HIV present in the body is not enough to cause immune deficiency, disease, or death by itself. Rather, it’s chronic inflammation, immune activation, immune exhaustion, and gut damage that leads to cell loss, immune collapse, opportunistic infections, and ultimately, death.

TOPVEIN-B6: Comprehensive Protection:

TOPVEIN-B6 acts as a powerful shield. Some of its compounds block HIV from entering cells, while others, natural antibiotics, antifungals, and antiparasitic, combat or prevent serious opportunistic infections and diseases that together constitute AIDS.

Opportunistic Infections and Diseases Targeted by TOPVEIN-B6:

TOPVEIN-B6 helps prevent, treat, and protect against a wide range of infections and diseases, including but not limited to:

1. Pneumocystis jirovecii pneumonia (P*P): Severe, potentially fatal pneumonia.

2. Candidiasis: Oral thrush, esophagitis, and vaginal yeast infections.

3. Tuberculosis (TB): Persistent cough, night sweats, weight loss, and potential spread beyond the lungs.

4. Cytomegalovirus (CMV) Infection: Retinitis (can cause blindness), colitis, esophagitis, pneumonia, encephalitis.

5. Toxoplasmosis: Brain inflammation, causing headaches, confusion, and seizures.

6. Cryptococcal Meningitis: Fungal meningitis leading to headaches, fever, and altered mental status.

7. Mycobacterium avium Complex (MAC) Infection: Disseminated infection causing fever, weight loss, and anemia.

8. Herpes Simplex Virus (HSV) Infections: Chronic ulcers, esophagitis, painful sores, and encephalitis.

9. Kaposi’s Sarcoma: Cancer of blood vessels, presenting as skin lesions and potential internal organ involvement.

10. Progressive Multifocal Leukoencephalopathy (PML): Brain disease causing weakness, speech and vision problems, cognitive decline.

11. Non-Hodgkin Lymphoma: Lymphatic cancer with swollen lymph nodes and systemic symptoms.

12. Histoplasmosis: Lung and organ infection, causing cough, fever, and enlarged liver/spleen.

13. Coccidioidomycosis: Fungal infection affecting lungs, skin, bones, joints, and brain.

14. Cryptosporidiosis: Severe, chronic diarrhea and dehydration.

15. Isosporiasis (Cystoisospora belli): Long-lasting diarrhea and abdominal pain.

16. HPV-related diseases: Ge***al warts and cancers such as cervical and a**l cancer.

17. Bacillary Angiomatosis: Vascular lesions, skin eruptions, and organ involvement.

18. Recurrent Bacterial Pneumonia: Frequent and severe lung infections.

19. Disseminated Herpes Zoster (Shingles): Painful skin rash, sometimes spreading to internal organs.

20. Hepatitis B and C Virus Co-infections: Chronic hepatitis, liver cirrhosis, and increased risk of liver cancer.

In addition to these, TOPVEIN-B6 is effective against persistent and resistant infections such as malaria, syphilis, gonorrhea, chlamydia, urinary tract infections (UTIs), and other sexually transmitted diseases.

TOPVEIN-B6 also addresses chronic constipation, a common problem among HIV-positive individuals.

In summary:

TOPVEIN-B6 provides comprehensive protection by blocking HIV entry, safeguarding new cells, and preventing or treating the full spectrum of opportunistic infections and diseases associated with HIV/AIDS.

CONTACT US:

Phone or WhatsApp:
+260977889136
Lusaka - Zambia.

TOPVEIN-B6 is a broad spectrum plant derived medicine used to treat various illnesses, including HIV-1 and AIDS. Its the...
07/04/2026

TOPVEIN-B6 is a broad spectrum plant derived medicine used to treat various illnesses, including HIV-1 and AIDS.

Its therapeutic potential has gained scientific interest because it contains six compounds which potentially prevents HIV from entering human cells, specifically, by targeting the initial stages of the viral life cycle.

A 2021 study identified six bioactive compounds in TOPVEIN-B6 that block HIV-1 entry, each with a distinct mechanism of action:

Oleanolic Acid & Palmitic Acid

· Mechanism of Action: Block the interaction between HIV-1's gp120 and the CD4 receptor on host cells.

Taxifolin

· Mechanism of Action: Disrupts the gp120-CD4 interaction, also known to inhibit HIV-1 infection.

Piceatannol

· Mechanism of Action: Prevents entry by targeting both cell and viral membranes.

Guibourtinidol-(4α→8)-epiafzelechin

· Mechanism of Action: Inhibits viral fusion with the host cell.

Cassiabrevone

· Mechanism of Action: A novel compound that blocks the gp120-CD4 binding and plays a major role in the crude extract's anti-HIV activity.

TOPVEIN-B6 has proven to be not only for the prevention of HIV but an AIDS therapy in totality.

FBC or FULL BODY COMPOUND is a Magnesium Complex food grade supplement.  As a complex of magnesium, it contains six diff...
07/04/2026

FBC or FULL BODY COMPOUND is a Magnesium Complex food grade supplement.

As a complex of magnesium, it contains six different types of manganesium, each with a distinct function.

This composition helps regulate blood pressure and prevent heart disease, improves insulin sensitivity for Diabetes management and supports nerve and muscle function.

The Six types of manganesium:

1. Magnesium Glycinate (High Absorption)

· Key Benefits: Reduces stress, promotes sleep, muscle relaxation, and bone health.

· Primary Use: Ideal for correcting a general magnesium deficiency and for managing anxiety and insomnia, as it's gentle on the stomach.

2. Magnesium Malate (Energy Production)

· Key Benefits: Boosts energy production, reduces muscle pain, and improves exercise performance.

· Primary Use: Often recommended for chronic fatigue syndrome and fibromyalgia due to its role in the Krebs cycle (energy production).

3. Magnesium Taurate (Cardiovascular Health)

· Key Benefits: Supports heart health, lowers blood pressure, and helps control blood sugar.

· Primary Use: Specifically for heart conditions, as taurine provides extra support for blood pressure and heart rhythm.

4. Magnesium Citrate (Bowel Movement)

· Key Benefits: Acts as an osmotic laxative to relieve constipation.

· Primary Use: Preparation for medical procedures (e.g., colonoscopy) and short-term relief of constipation.

5. Magnesium Oxide (Low Bioavailability)

· Key Benefits: Contains high elemental magnesium but is poorly absorbed; used primarily as an antacid and laxative.

· Primary Use: Treating heartburn, acid indigestion, and constipation.

6. Magnesium Threonate (Brain Health)

· Key Benefits: It is unique for its ability to cross the blood-brain barrier. Studies show improvements in cognitive performance, memory, and reaction time.

· Primary Use: Specifically formulated to support brain health and cognitive function.

LIVON-X is for the treatment of the Leaky Gut. Leaky Gut, also known as increased intestinal permeability, is a conditio...
07/04/2026

LIVON-X is for the treatment of the Leaky Gut.

Leaky Gut, also known as increased intestinal permeability, is a condition where the lining of your small intestine becomes damaged, creating gaps that allow harmful substances like toxins and undigested food particles to "leak" into your bloodstream.

This can trigger inflammation and a range of health issues which include False HIV positives, AIDS, and cancer.

COMMON SYMPTOMS:

The symptoms of a leaky gut are often non-specific and can overlap with many other conditions.

The most common signs fall into several categories:

· Digestive Issues:

Persistent bloating, excessive gas, cramps, diarrhea, constipation, and Irritable Bowel Syndrome (IBS)-like symptoms are frequently reported.

· Systemic Symptoms:

These include chronic fatigue, headaches or migraines, "brain fog" (difficulty concentrating), and joint or muscle pain.

· Immune Reactions:

Development of new food sensitivities or intolerances, as well as increased allergies and frequent infections.

· Skin Problems:

Conditions like eczema, acne, and psoriasis are also linked to increased gut permeability.

· Mood-Related Issues:

Some people experience anxiety, depression, or mood swings, which may be connected to the gut-brain axis.

LEAKY GUT ASSOCIATED DISEASES & CONDITIONS

Leaky gut is frequently seen in people with:

· Autoimmune Diseases:

The strongest links are with celiac disease, rheumatoid arthritis, type 1 diabetes, multiple sclerosis, and lupus.

· Inflammatory Bowel

Diseases (IBD): Both Crohn's disease and ulcerative colitis are strongly associated with increased intestinal permeability.

· Metabolic & Endocrine

Issues: Links have been suggested with obesity, fatty liver disease, and metabolic syndrome.

· Allergic Conditions: Conditions like asthma and allergic rhinitis (hay fever) have also been linked to a compromised gut barrier.

· Neurological & Psychiatric Conditions: Emerging research is exploring links with autism spectrum disorder (ASD) and depression.

PH-TEA is a broad spectrum medicine for the treatment of conditions caused by acidosis. Acidosis is a condition where yo...
07/04/2026

PH-TEA is a broad spectrum medicine for the treatment of conditions caused by acidosis.

Acidosis is a condition where your blood and body fluids have too much acid (pH below 7.35).

Acidosis is not a disease itself, but a sign of an underlying problem.

The two main types are metabolic (kidney/loss of bicarbonate) and respiratory (lung/CO2 buildup).

Common Symptoms

· Rapid, shallow, or deep labored breathing (Kussmaul breathing)

· Confusion, drowsiness, or fatigue

· Headache and sleepiness

· Nausea, vomiting, or abdominal pain

· Rapid heart rate and palpitations

· Fruity-smelling breath (specifically in diabetic ketoacidosis)

Diseases & Conditions Caused by or Linked to Acidosis

· Diabetic Ketoacidosis (DKA) – a life-threatening complication of diabetes.

· Lactic Acidosis – from sepsis, shock, heart failure, or severe dehydration.

· Chronic Kidney Disease (CKD) – kidneys fail to excrete acid.

· Respiratory Failure – from severe COPD, pneumonia, or asthma (leading to respiratory acidosis).

· Severe Diarrhea or Cholera – loss of bicarbonate causes metabolic acidosis.

· Poisonings – methanol, ethylene glycol (antifreeze), or salicylate (aspirin) overdose.

Mild, chronic acidosis (often diet-related) is linked to worsening bone density loss (osteoporosis) and muscle wasting over time.

Acidosis also causes False HIV positives and cancer.

Acidosis is also a condition which causes all viruses to become active. Without it, viruses become deactivated and incapable of causing infection.

PH-TEA is also used to ease gastritis and acid refluxes.

WHAT IS PH-TEA.?DEFINITION:PH-TEA is an over-the-counter medicine made from inorganic compounds with active agents being...
07/04/2026

WHAT IS PH-TEA.?

DEFINITION:

PH-TEA is an over-the-counter medicine made from inorganic compounds with active agents being ionic sodium salts whose molecular formular is C6H5Na307 and pH 8 - 9.

NOTE: These inorganic compounds are FDA approved for various human use in medicine, cosmetics, and other industrial applications.

DESCRIPTION:

PH-TEA is white, crystalline powder or white, granular crystals, slightly deliquescent in moist air, freely soluble in water, practically insoluble in alcohol and has a sour taste.

MEDICAL USES:

From the medical point of view, it is used as alkalinizing agent. It works by neutralizing excess acid in both the blood and urine. It has been indicated for the treatment of metabolic acidosis.

These ionic sodium salts are also known as lysosomotropical agents for that once the crystals change into nanoparticles, they easily pe*****te plasma membranes of cells and directly into the cytoplasma and right into endosomes and lysosomes to cause a change in internal pH which in turn causes a deactivation of viruses.

Further, these ionic sodium salts are also known as calcium chelators for that once they bind to cells with extracellular calcium, they form soluble complexes that reduce this calcium availability on cells.

Remember that HIV enters host cells through a calcium-dependent mechanism, with reference to a paper: HIV Calcium Dependence - Bhattacharya, A., et al. (2014). "Structural basis of HIV-1 capsid recognition by PF74 and CPSF6." PNAS, 111(52), 18625-18630.

Thus, two critical factors in HIV’s lifecycle are its dependence on calcium (Ca²⁺) signalling and sensitivity to pH fluctuations.

That means, calcium is essential for viral fusion, reverse transcription, and budding, while pH influences envelope protein conformation and viral entry (Harrich et al., 2015; Strebel & Bouamr, 2016).

This means, if calcium can be removed or chelated, the entry points for HIV will be blocked. This blocking of entry points will result in HIV free cells.

Thus, PH-TEA is both a calcium chelator and alkalinization agent, potentially disrupting HIV replication by altering the ionic and pH environment necessary for viral entry, fusion, and maturation.

MEDICAL FACTS:

1. Calcium Chelation – Depletes extracellular Calcium (Ca²⁺), inhibiting viral entry, reverse transcription, and budding.
2. Alkalinization – Elevates extracellular pH, impairing viral fusion and uncoating.

QUANTITATIVE pH THRESHOLDS:

1. Fusion efficiency drops by 50% at pH 7.6 (Puri et al., 1998)
2. Viral infectivity decreases by 90% at pH 8.0 (Melikyan, 2014)

OTHER MEDICAL USES:

In general, medical use, the sodium minerals are commonly used in hospitals in liquid form as saline and commonly known by people as drips.

However, a stronger formulation these ionic salts are medically known to prevent activation of the clotting cascade by chelating calcium ions. They are also used to neutralizes acid in the stomach and urine, raising the pH.

The active sodium salts are ingredients used for the anticoagulation of whole blood as part of automated apheresis procedures.

They are used as an anticoagulant during plasmophoresis as well as a neutralizing agent in the treatment of upset stomach and acidic urine.

In medicine, these ionic active sodium salts in PH-TEA are also used in the treatment of several health conditions which include the following:

Acidosis, Allergic cough, Allergies, Asthma, Asthma Chronic, Cough, Common Cold, Cough, Coughing caused by Bronchitis, Dehydration, Fibroids, Gouty Arthritis, Heartburn, Metabolic Acidosis, Phlegm, Airway secretion clearance therapy, Oral rehydration therapy, Plasmapheresis, Urine alkalinization therapy, Fluid and electrolyte maintenance therapy, Irrigation during surgical procedures, Irrigation of the ocular surface therapy.

HISTORICAL USES:

USED IN SPANISH FLU:

During the Spanish flu of March 1918 to 1919, these active ionic sodium salts were formulated and employed to wipe out the flu which had claimed lives of over 100 million people from China, India, Europe, and the US.

USED TO WIN NOBEL PRIZES:

One scientist known as Otto Heinrich Warburg formulated this compound in 1924 to solve the problem of cancer.

He did this by first formulating a hypothesis now known as The Warbug hypothesis (or the Warburg effect) which later won him two Nobel Prizes with the first being in 1931 and a second one in 1944 for his cancer research.

He stated the following: “The prime cause of cancer is the replacement of the respiration of oxygen in normal body cells by a fermentation of sugar”.

CONCLUSION:

PH-TEA’s dual action as a calcium chelator and alkalinizing agent, presents a promising adjunctive strategy against HIV.

By disrupting calcium (Ca²⁺) -dependent viral entry and pH-sensitive fusion, it may complement existing ART.

Further, it can be applied to neutralize food poisoning, chemical poisoning, metal poisoning such as aluminum and mercury in vaccines.

WHAT IS TOPVEIN-B6INTRODUCTION:TOPVEIN-B6 is a plant derived broad-spectrum acting antiviral medicine primarily designed...
07/04/2026

WHAT IS TOPVEIN-B6

INTRODUCTION:

TOPVEIN-B6 is a plant derived broad-spectrum acting antiviral medicine primarily designed to stop HIV from infecting healthy human cells in both infected and uninfected persons.
Additionally, TOPVEIN-B6 is designed to combat opportunistic infections and diseases in immunocompromised individuals. As such, it is a duo-acting medicine to be administered both as a prophylaxis and therapy.

With its broad-spectrum action, TOPVEIN-B6 is in the anti-retroviral category of Entry Inhibitors class of anti-viral drugs.

TOPVEIN-B6 is a broad-spectrum antiviral medicine as it comprises six bioactive antiviral compounds, each with varying potency and distinct mechanisms of action that all primarily block HIV from entering cells.

Each of these six bioactive antiviral compounds derived from a medicinal plant found in Sub-Saharan Africa, has been extensively studied by scientists from different countries and schools which include Africa, the US, Europe, and China in the period between 2021 and 2026, with all arriving at the same conclusion in their respective literature publicly available in various science and medical journals.

EFFICACY VALIDATION BY A ZAMBIAN TEAM:

A team of Zambian scientists from both the University of Zambia (Department of Pharmacy, School of Health Science) and Levy Mwanawasa Medical University (Department of Pharmacy, School of Health Science) who together a**lysed the bioactive compounds composed in this formula of TOPEIN-B6, validated the anti-viral activity of these compounds in their literature published in one science journal available online:

That, “Polypeptides, particularly antiviral peptides composed in TOPVEIN-B6 formula, exert antiviral effects by blocking viral fusion or adsorption and by utilizing disulfide bridges to stabilize their active structure.”

Polypetides are simply a diverse group of molecules or bioactive compounds found in plants that have gained significant amount of attention for their potential health benefits.

These polypetides are found in leaves, stem barks, roots, fruits, and seeds of most plants and have been found therapeutically effective against all illnesses suffered by both humans and animals on earth.

EFFICACY VALIDATION BY A LUXEMBURG TEAM:

In laboratory settings conducted by scientists from Luxemburg Institute of Health who went further in their research to demonstrate how these bioactive compounds composed in the formula of TOPEIN-B6 block HIV-1 entry, found six bioactive compounds which effectively inhibit HIV-1 infection with an IC50 of 21.75 µg/mL, as well as reverse the destructive effects of the virus on cells.
These team observed that this potent activity is likely the result of all six compounds working in concert.

The Luxemburg team further isolated and named these compounds which effectively block HIV-1 entry as: Piceatannol, Oleanolic Acid, Cassiabrevone, Guibourtinidol-(4α→8)-epiafzelechin, Palmitic Acid, and Taxifolin.

This research team explicitly states that through computer modelling and lab tests, these compounds have "different modes of action”.

1. Cassiabrevone – Works by blocking the binding activity between the viral envelope protein gp120 and the CD4 receptor on the surface of human immune cells. This interaction is the critical initial "handshake" that allows HIV to latch onto a cell it intends to infect.

2. Palmitic Acid – Works by preventing viral fusion and entry by blocking the host’s CD4 receptor.

3. Piceatannol - Works as a broad-spectrum entry inhibitor that disrupts the cell membrane to act as a physical barrier on the cell membrane.

4. Oleanolic Acid - Works by blocking the final necessary cut in a viral protein precursor (Gag), leading to the release of immature, non-infectious virus particles.

5. Taxifolin - is a multi-target inhibitor affecting protease, reverse transcription, and viral entry. most potent HIV-induced cytopathic activity" among the isolated compounds, completely inhibiting the virus's damaging effects on cells.

6. Guibourtinidol-(4α→8)-epiafzelechin - Blocks HIV-1 entry, but its exact molecular target is still being studied.

The team further observed that all of these isolated six compounds fall within the “Entry Inhibitor” class because they all act to block HIV before it can enter and infect a human cell.
These six compounds represent various sub-classes of entry inhibitors based on their specific targets within the entry process which include: Attachment and Fusion, or Multi-pathway inhibition.

THE MULTI-LAYERED DEFENSE: HOW SYNERGY WORKS

The synergy arises from attacking the viral entry process at multiple, distinct stages simultaneously. Think of it as placing several locks on a door, an intruder would need to pick all of them to get through.

Layer 1: Blocking the Initial Attachment:

The first step of infection is the virus docking onto the host cell. Cassiabrevone precisely blocks the "key" (viral gp120) from fitting into the "lock" (host CD4 receptor). Similarly, palmitic acid gums up the "lock" itself by binding directly to the CD4 receptor. By targeting the same critical interaction from different angles, they make it much harder for the virus to attach.

Layer 2: Disrupting the Membrane Environment:

Even if the virus avoids the first layer of defence, it must fuse with the host cell membrane to enter. Piceatannol acts as a general disruptor here, altering the physical properties of both the viral and cellular membranes to hinder the fusion process. This mechanism is non-specific, making it a potent broad-spectrum barrier.

Layer 3: Ambushing Other Entry Pathways:

Compounds like oleanolic acid and taxifolin add to the synergy by blocking HIV-1 entry as well, but their known activity against other viral targets (like protease or reverse transcriptase) suggests they could also inhibit the virus if it manages to bypass the initial entry blocks. Guibourtinidol-(4α→8)-epiafzelechin contributes another, as-yet-unidentified block to the entry process, further plugging potential gaps in the defence.

HOW HIV CELL ENTRY IS BLOCKED:

Peptides block HIV entry in two different ways:

1. By competing for attachment space with the actual virus, and
2. By directing binding to the virus itself.

Peptides are naturally designed to mimic the part of the viral protein that binds to the host receptor. Thus, these “decoy’ peptides bind to the host cell receptor, occupying the docking station so the virus cannot attach.

Other peptides bind directly to the viral attachment protein. By covering or altering the shape of the viral protein, they prevent it from interacting with its target receptor on the cell.

COMPARING TOPVEIN-B6 TO ARV’S:

Thus, while conventional ARV regimens typically combine two or three drugs from different classes to suppress HIV, TOPVEIN-B6 uniquely integrates six bioactive compounds in a single formulation. The synergy of these compounds target HIV at the earliest stage of its lifecycle, effectively preventing viral entry into healthy human cells.

This approach not only enhances efficacy and reduces the likelihood of resistance but also addresses biologically and therapeutically significant targets.

PRELIMINARY LABORATORY DATA:

Laboratory vs. Human Data:

The six bioactive compounds we discussed above, have demonstrated anti-HIV activity in cell cultures and biochemical assays. This is promising scientific groundwork, but it is very different from clinical evidence in humans.

Effective in Human Tissue Models:

Beyond cell cultures, palmitic acid was shown to inhibit HIV-1 infection by up to 50% in an ex vivo human cervical tissue model, which closely mimics the conditions of vaginal HIV transmission.

Excellent Safety Profile:

when a paste was rubbed in the vaginas, it was observed that, the concentrations that inhibit HIV were not toxic to the cervical tissue and, importantly, did not harm beneficial Lactobacillus bacteria (like L. crispatus and L. jensenii), which are a critical part of healthy vaginal flora.

Therapeutic Window yet to be established:

While animal studies used doses up to 1000 mg/kg without observed toxicity, the effective therapeutic dose for anti-HIV activity in humans is completely is yet to be established. The gap between a potentially effective dose and a toxic dose has not been established in humans as more research needs to be done.

THE US GOVERNMENT CREATED HIV(Even If You Are Brain Dead, This Article Will Wake You Up)--------------------------------...
07/04/2026

THE US GOVERNMENT CREATED HIV
(Even If You Are Brain Dead, This Article Will Wake You Up)
--------------------------------------------------------------------------
PAPER REFERENCES:

1. BBC News (2003). Alternative 3: The Cult Sci-Fi Hoax That Refused to Die.
2. Meadows, D.H. et al. (1972). The Limits to Growth. Universe Books.
3. The Global 2000 Report to the President (1980). U.S. Government Printing Office.
4. U.S. House of Representatives, Department of Défense Appropriations for 1970, Hearings, 91st Congress, 1st Session, Part 5 (1969), p. 129.
5. U.S. Senate (1977). Biological Testing Involving Human Subjects by the Department of Défense.
6. Lo, S.-C. (1993). “Pathogenic mycoplasma.” US Patent 5,242,820.
7. U Thant, Speech to the United Nations General Assembly, 1969.
8. Oldstone, M.B.A. (1972). “Virus-associated immunopathology.” Bulletin of the World Health Organization,
--------------------------------------------------------------------------
INTRODUCTION:

To start with, let us agree that what is code-named HIV is not a naturally occurring microbe. Let us agree that HIV is a man-made project, and was intentionally made to serve a special purpose.
I know, this is a huge claim to make.

The obvious question to this claim should be: What evidence is there to substantiate this claim?

To substantiate any of my claims above, I will make references to the paper documents listed above:

Here we go:

1. The 1957 Huntsville Study and “Alternative 3.”

In 1957, scientists met in Huntsville, Alabama, (US) and conducted a study that led to a secret program called “Alternative 3.” While this meeting and program were meant to be secret, some information leaked, leading to the creation of a documentary by Anglia Television on 20 June 1977 and broadcast on British television programs in the same year (1977).

The same leaked information was later published as a book by Leslie Watkins, Alternative 3. The secret meeting, which was code-named Alternative 3, discussed population control measures.

2. The Club of Rome, Limits to Growth

Another study on challenges of population growth was conducted in 1968 by a Think Tank known as the Club of Rome. That study report was titled The Limits to Growth” and published by Meadows, D.H. et al. (1972).

To be precise, the study was organised in April 1968, at the Accademiadei Lincei in Rome Italy. Scientists met at the instigation of Dr. Aurelio Peccei, a member of The Club of Rome.

The fear in their report was: “If the present growth trends in world population, industrialization, pollution, food production, and resource depletion continue unchanged, the limits to growth on this planet will be reached sometime within the next one hundred years.” - The Limits to Growth, 1972.

The study warned about environmental constraints on unchecked population and economic growth. This led to the conclusion that civilization would collapse after 2000 unless the population was curtailed.

Dr. Aurelio Peccei, representing the Club of Rome, made top-secret recommendations to the global elite, including the development of a microbe to attack the immune system.

The chief recommendation was to develop a microbe that would attack the autoimmune system and render the development of a vaccine impossible. The orders were given to develop the microbe and to also develop an acute and a prophylactic.

The microbe would be used against the general population and would be introduced by a vaccine administered by the World Health Organisation.

The prophylactic was to be used by the ruling elite. The cure will be administered to the survivors when they decide that enough people have died. It will be announced as newly developed.

THE FUNDING:

Funding for this project was obtained from the U.S congress under H.B. 15090 where $10 million was given to the Department of Defence to produce a synthetic biological agent, an agent that does not naturally exist and for which no natural immunity could have been acquired.

This information is contained in a document called: The U.S. House of Representatives, Department of Defence Appropriations for 1970, Hearings before a Subcommittee of the Committee on Appropriations, 91st Congress, 1st Session, Part 5 (1969), p. 129.
Congressional testimony:

In 1969, Dr. Donald MacArthur of the U.S. Department of Défense testified before Congress about the feasibility of creating a “synthetic biological agent” for military purposes, with $10 million proposed for research. This testimony is part of the public record:

“Within the next 5 to 10 years, it would probably be possible to make a new infectious microorganism which could differ in certain important aspects from any known disease-causing organisms.”

Most important of these is that it might be refractory to the immunological and therapeutic processes upon which we depend to maintain our relative freedom from infectious disease.

This project was carried out at Fort Detrick in Maryland, the centre of the U.S. biological warfare research responsible for the development of the offensive biological weapons program in collaboration with the U.S. Army Medical Research Institute of Infectious Diseases (USAMRIID) and several universities across the US.

And since large populations were to be decimated, the ruling elite decided to target the undesirable elements of society for extermination. The targeted undesirables were the black, Hispanic, and homosexual populations.

The name of the project that developed this weapon, code-named HIV and AIDS is called MKNAOMI, a project overseen by the CIA and Special Operations Division at Fort Detrick.

This project, MKNAOMI was a real U.S. biological warfare program active from the 1950s to the 1970s, focused on the development and stockpiling of bioweapons.

The testimonies about the biological testing involving human subjects by the Department of Defense, regarding MKNAOMI, a project overseen by the CIA are recorded in a document called:

Hearings before the Subcommittee on Health and Scientific Research of the Committee on Human Resources, United States Senate, 95th Congress, 1st session, March 8 and May 23, 1977.

CONGRESSIONAL TESTIMONIES:

This information is contained in one of the CIA documents made available to the public, a testimony to Congress given by Mr. Nathan Gordon, the Chief of the Chemistry Branch of the Technical Services Division of the CIA as additional testimony of the agency’s possible use of an extensive virus stockpile to assistant intelligent agency scientists in their work on mass immunization projects.

The document further reveals that the CIA had been receiving deadly poisons manufactured by USPHS and delivered to Fort Detrick for use in human experiments and covert operations.

AIDS is not a natural disease. It is a man-made biological weapon developed by the US Federal government.

WHAT WAS CREATED UNDER MKNAOMI?

What was created is originally called Mycoplasma fermentans incognitus with a US patent number 5,242,820. It was created by Dr. Shi-Ching Lo of the US Armed Forces Institute of Pathology based in Washington D.C.

This microorganism does not naturally exist. It was instead created in the laboratory using a recombination technology. A system of splicing and combining two or more organisms to develop one new and distinct organism.

In this case, this type of mycoplasma was created out of a Brucella bacterium mutated with a visna virus.

Thus, what we all know as HIV is a genetic recombinant of two microbes spliced together. Other types were made of bovine leukemai virus (cow) and the visna virus (sheep) which were the cultured in human tissue.

This Mycoplasma fermentans incognitus is what causes immunodepression and gives rise to opportunistic infections.

If you quickly google: Mycoplasma fermentans incognitus, what shows up is the following:

"Mycoplasma fermentans incognitus" refers to a strain of Mycoplasma fermentans that was initially identified as a distinct "new" mycoplasma called Mycoplasma incognitus. It was initially isolated from patients with AIDS and was later determined to be a strain of M. fermentans.

This strain has been implicated in various diseases, including systemic infections and potentially contributing to the progression of HIV/AIDS.

This mycoplasma is a slow-growing, stealth-type organism that can cause the patient to be very ill. It activates the immune system, then can successfully hide from it within the host immune cells.

Mycoplasmas naturally exist as bacteria. However, unlike bacteria, this Mycoplasma fermentans incognitus has no cell wall. This enables it to invade tissue cells, incorporate the cell’s nutrients, and using the cell to replicate itself (much like retroviruses).

When this mycoplasma breaks out of the cell, it takes a piece of the host cell membrane with it. When the immune system attacks the mycoplasma, it also gets “turned on” to attacking the host cell.

In this way, an autoimmune condition can begin. Autoimmune conditions associated with this mycoplasma include arthritis, fibromyalgia, myositis, thyroid dysfunction,adrenal dysfunction, lupus, multiple sclerosis and Lou Gehrigs Disease.

According to CIA documents in my possession, this so-called AIDS virus (or HIV whose official name is Mycoplasma fermentans incognitus) was laced as a complement into various vaccinations for smallpox, polio, Hepatitis B among others by the US Army Biowarfare Unit in Ft. Detrick, Maryland in the 1970’s.

3. The Global 2000 Report and U.S. Government Funding
Global 2000 most commonly refers to the Global 2000 Report to the President, a comprehensive study commissioned by the United States government in 1977 under President Jimmy Carter.

The report concluded that if present trends continued, the world in 2000 would be more crowded, more polluted, less stable ecologically, and more vulnerable to disruption than the world at the time of the study. It warned of serious environmental and resource challenges and called for cooperative international action and significant policy changes to avoid negative outcomes.

IMPLEMENTING THE MKNAOMI THROUGH THE WORLD HEALTH ORGANISATION:

WHO Bulletin Reference: WHO Bulletin 1972, Vol. 47, No. 2, pp. 257-264

The CIA, collaborating with the World Health Organisation (WHO) requested scientists to create HIV as per an article published in the Bulletin of the WHO in 1972, Volume 42, No. 2 pages 257-264.

The title of the Article is:

Virus-associated immunopathology: animal models and implications for human disease: 1. Effects of viruses on the immune system, immune-complex diseases, and antibody-mediated immunologic injury.

In the article, of all recommendations forwarded, number 3 reads as follows:

An attempt should be made to ascertain whether viruses can in fact exert selective effects on immune function e.g. by depressing 7s and 19 s antibody or by affecting T cell function as opposed to B cell function (Allison et, al, 1971).

The possibility should be looked into that the immune response to the viruses may itself be impaired if the infecting virus damages more or less selectively the cells responding to the viral antigens.

If this proves the case, virus-induced immunodepression might conceivably be highly instrumental in prolonging certain virus infections such as murine leukaemia, hepatitis sub-acute sclerosing panecephalitis, or infections caused by LDV, LCMV, or ADV.

Hold on!

"What the WHO is saying in plain English is, let’s cook up a virus that selectively destroys the T-cell system of man, an acquired immune deficiency.'"

Is this not AIDS?

The author of this publication was Dr. Michael B. A. Oldstone a prominent researcher at the Scripps Clinic and Research Foundation in La Jolla, California.

He was a leading expert in viral pathogenesis and immunology, particularly known for his work on how viruses cause disease by modifying the host's immune function.

Address

Lusaka
10101

Alerts

Be the first to know and let us send you an email when Dr. Mendez Fernandez - ND. posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Business

Send a message to Dr. Mendez Fernandez - ND.:

Share